Month: November 2022

Content Endorsement in Power BI, Part 1, The Basics

As you may already know, Power BI is not a report-authoring tool only. Indeed, it is much more than that. Power BI is an all-around data platform supporting many aspects you’d expect from such a platform. You can ingest the data from various data sources, transform it, model it, visualise and share it with others. Read more about what Power BI is here.

One of the key aspects of users’ experience in Power BI is their ability to collaborate in creating and sharing content, making it an easy-to-use and convenient platform. But the convenience comes with a cost of having a lot of shared content in large organisations raising concerns about the content’s quality and trustworthiness. It would be hard, if not impossible, to identify the quality of the contents without a mechanism to identify the quality of the contents. Content endorsement is the answer to this.

In this series

…
Read More

Although getting better loan terms is the main incentive and reason people choose to refinance, you should know that individual circumstances are more important than changing the terms or rates. 

It would be best to base your decision on your circumstances, which is essential to remember. Everything depends on your preferences, but mortgage rates should not be the essential factor for deciding. After checking here, you can learn how to refinance a commercial mortgage with ease. 

Instead, you should stay with us to learn more about essential considerations you should learn before you make up your mind. 

  1. Home Equity

The initial information you should review and understand is your current home equity. Therefore, if your household is worth less than it was before you got the initial mortgage, you have reached a point of negative equity. As a result, you should avoid refinancing because it does not come with …

Read More

Giant Biogene Holding, a China skincare products supplier that listed at the Hong Kong Stock Exchange on Nov. 4, has raised the equivalent of $10 million though the sale of 3.39 million over-allotment shares at HK$24.30, or approximately $3.11, each, the company said in a filing on Sunday.

The sale added to the HK$495.8 million Giant raised ahead of the start of public trading. Giant lost 7% and traded at HK$25 at Hong Kong Stock Exchange as of noon today, valuing the stake held by Giant co-founder and executive director Fan Daidi at the equivalent of $2 billion.

Fan, 56, is also the chief scientific officer and dean of the Institute of Biomedical Research of Northwest University in Xi’an. She holds a minority stake in Xi’an Triangle

…
Read More